Vanguard reports 6.20M shares (7.52%) in Labcorp
Vanguard Capital Management reports beneficial ownership of 6,201,512 shares of Labcorp Holdings Inc common stock, representing 7.52% of the class as of 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vanguard Capital Management reports beneficial ownership of 6,201,512 shares of Labcorp Holdings Inc common stock, representing 7.52% of the class as of 03/31/2026. The filing shows sole voting power of 825,392 shares and sole dispositive power over 6,201,512 shares. The Schedule 13G is signed on 04/28/2026 by Ashley Grim.
Insights
Large passive holding disclosed: 6,201,512 shares (7.52%).
Vanguard Capital Management reports beneficial ownership of 6,201,512 shares, equal to 7.52% of Labcorp common stock as of 03/31/2026. The position is reported under Schedule 13G, typically used for passive investors.
Voting and dispositive splits show 825,392 shares with sole voting power and full dispositive power over the reported holdings. Future changes depend on trading by Vanguard-managed funds and affiliates; subsequent filings will update positions.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
Sole dispositive power regulatory
Sole voting power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Vanguard Capital Management hold in Labcorp (LH)?
Is this Schedule 13G filing indicative of active control of Labcorp?
Which entities are included in Vanguard's reported ownership?
When was the Schedule 13G signed and filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.